Document Detail

An in vitro study of Hoechst 33342 redistribution and its effects on cell viability.
MedLine Citation:
PMID:  16323574     Owner:  NLM     Status:  MEDLINE    
Although Hoechst 33342 (H342) is frequently used to label donor cells in cell transplantation research, it has been noted that it might secondarily label the host cells. Furthermore, its potential toxicity leading to cell death has been described. We studied the time course of H342 redistribution from the primary labeled rat bone marrow stromal cells (rBMSC) into the non-labeled rBMSC population over 7 days in culture; we evaluated the nuclear H342 fluorescence intensity as a possible criterion for distinguishing the primary from the secondary labeled cells, and determined the viability of rBMSC after an overnight incubation in 1 microg/mL of H342. H342 labeled >50% of the initially non-labeled cells within the first 6 hours and almost 90% within a week. Nuclear fluorescence intensity was a reliable criterion for distinguishing primary and secondary labeled cells within the first 24 hours, but less so at later time points. The percentage of either apoptotic or necrotic cells did not rise acutely after the overnight incubation in 1 microg/mL of H342. Although a 12-hour incubation of rBMSC in 1 microg/mL of H342 did not cause acute cell death, H342 rapidly and extensively redistributed into non-labeled cells, which makes H342 a relatively unsuitable marker for cell transplantation research.
N Mohorko; N Kregar-Velikonja; G Repovs; M Gorensek; M Bresjanac
Related Documents :
19379734 - Calcium-independent phospholipase a2 regulates retinal pigment epithelium proliferation...
8811514 - Cell cycle time of murine neopallial cells in vitro.
10093514 - Controlled introduction of selenium into chlorella cells.
8336924 - Feasibility of proliferation studies using the brdu and mtt assays with a head and neck...
23566714 - Il-10-producing regulatory b cells (b10 cells) in autoimmune disease.
2079964 - Reduced dna-repair capacity in cells originating from a progeria patient.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Human & experimental toxicology     Volume:  24     ISSN:  0960-3271     ISO Abbreviation:  Hum Exp Toxicol     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-12-05     Completed Date:  2006-02-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9004560     Medline TA:  Hum Exp Toxicol     Country:  England    
Other Details:
Languages:  eng     Pagination:  573-80     Citation Subset:  IM    
LNPR, Faculty of Medicine, Institute of Pathophysiology, Zaloska, University of Ljubljana, Slovenia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Area Under Curve
Benzimidazoles / metabolism,  pharmacology*
Bone Marrow Cells / drug effects*,  metabolism
Bone Marrow Transplantation / methods
Cell Survival / drug effects
Cells, Cultured
Fluorescent Dyes / metabolism,  pharmacology*
ROC Curve
Rats, Wistar
Staining and Labeling
Time Factors
Reg. No./Substance:
0/Benzimidazoles; 0/Fluorescent Dyes; 23491-52-3/HOE 33342

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of dantrolene on lipid peroxidation, lutathione and glutathione-dependent enzyme activities i...
Next Document:  Safety and tolerability of repeated administration of pyridoxal 2-chlorobenzoyl hydrazone in rabbits...